Speaker illustration

Mr Alexandar Dukanovic

Gentofte University Hospital, Copenhagen (Denmark)

Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk: A Danish nationwide cohort study.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

Non-vitamin K antagonist oral anticoagulants according to predicted risk of stroke and bleeding among patients with atrial fibrillation: Danish nationwide time trends 2011-2015

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation

Thumbnail

This platform is supported by

logo Novo Nordisk